ACUT
Accustem Sciences Inc.Company Information
- Company Name
- Accustem Sciences Inc.
- CIK
- CIK0001850767
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- ACUT: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ACUT
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-13
- Last sale
- —
- Shares purchased (TTM)
- 167,193
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 2.56%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | - | - | - | 2 | 2 | 2 | - | - | - | - | - | - | ||||||
| Assets Current | 0 | 0 | 0 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets | 2 | 2 | 2 | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Other Liabilities Current | 5 | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Liabilities Current | 6 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
| Liabilities | 6 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 4 | 4 | 4 | 4 | 4 | ||||||
| Retained Earnings Accumulated Deficit | -11 | -10 | -10 | -9 | -9 | -8 | -8 | -8 | -7 | -7 | -7 | -6 | ||||||
| Stockholders Equity | -4 | -4 | -3 | -3 | -3 | -2 | -3 | -3 | -3 | -3 | -2 | -2 | ||||||
| Liabilities And Stockholders Equity | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 16 | 16 | 16 | 16 | 16 | 16 | 12 | 11 | 11 | 11 | 11 | 11 | ||||||
| Shares Outstanding | 16 | 16 | 16 | 16 | 16 | 16 | 12 | 11 | 11 | 11 | 11 | 11 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAccustem Sciences Inc. (ACUT) — SEC Financial Statements & Analysis
Accustem Sciences Inc. (ACUT) is a pharmaceutical preparations company, incorporated in DE. Accustem Sciences Inc. trades on OTC as: ACUT. Accustem Sciences Inc. (ACUT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Accustem Sciences Inc. carries a market cap of $4.59M, a P/E ratio of -2.78x, a P/B ratio of -1.11x, a P/S ratio of 46.62x, an enterprise value of $4.64M, and an EV/EBITDA multiple of -2.81x. On profitability, it posts an operating margin of -1679.61%, a net margin of -1679.61%, a Return on Equity (ROE) of 49.69%, and a Return on Assets (ROA) of -102.66%. Per share, it reports EPS of $-0.10, diluted EPS of $-0.10, free cash flow per share of $-0.07, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 7.18% year-over-year and EPS growth of 7.18% year-over-year. On the balance sheet, it maintains a current ratio of 0.02x, a quick ratio of 0.00x, working capital of $-5.62M, a debt-to-equity ratio of -1.39x, a debt ratio of 3.56, free cash flow of $-1.20M (TTM), and net debt of $49.71K. Figures sourced from SEC EDGAR.
- Market Cap
- $4.59M
- P/E TTM
- -2.78x
- EPS TTM
- $-0.10
- P/B TTM
- -1.11x
- ROE TTM
- 49.69%
- ROA TTM
- -102.66%
- Debt To Equity
- -1.39x
- Free Cash Flow TTM
- $-1.20M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Accustem Sciences Inc. in?
Accustem Sciences Inc. (ACUT) operates in the Pharmaceutical Preparations industry.
What exchange does ACUT trade on?
Accustem Sciences Inc. (ACUT) trades on the OTC.
Where is Accustem Sciences Inc. incorporated?
Accustem Sciences Inc. is incorporated in DE.
When was Accustem Sciences Inc. (ACUT)'s most recent SEC filing?
Accustem Sciences Inc. (ACUT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ACUT's market cap?
Accustem Sciences Inc. (ACUT) has a market capitalization of $4.59M as of 2026-06-30.
What is ACUT's EPS (earnings per share)?
Accustem Sciences Inc. (ACUT)'s trailing twelve month EPS is $-0.10 as of 2026-06-30.
What is ACUT's ROE (return on equity)?
Accustem Sciences Inc. (ACUT)'s trailing twelve month Return on Equity (ROE) is 49.69% as of 2026-06-30.
What is ACUT's ROA (return on assets)?
Accustem Sciences Inc. (ACUT)'s trailing twelve month Return on Assets (ROA) is -102.66% as of 2026-06-30.
What is ACUT's EV/EBITDA?
Accustem Sciences Inc. (ACUT)'s trailing twelve month EV/EBITDA is -2.81x as of 2026-06-30.